510 related articles for article (PubMed ID: 30053214)
1. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Boudville N; Johnson DW; Zhao J; Bieber BA; Pisoni RL; Piraino B; Bernardini J; Nessim SJ; Ito Y; Woodrow G; Brown F; Collins J; Kanjanabuch T; Szeto CC; Perl J
Nephrol Dial Transplant; 2019 Dec; 34(12):2118-2126. PubMed ID: 30053214
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
Perl J; Fuller DS; Bieber BA; Boudville N; Kanjanabuch T; Ito Y; Nessim SJ; Piraino BM; Pisoni RL; Robinson BM; Schaubel DE; Schreiber MJ; Teitelbaum I; Woodrow G; Zhao J; Johnson DW
Am J Kidney Dis; 2020 Jul; 76(1):42-53. PubMed ID: 31932094
[TBL] [Abstract][Full Text] [Related]
3. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients.
Campbell DJ; Brown FG; Craig JC; Gallagher MP; Johnson DW; Kirkland GS; Kumar SK; Lim WH; Ranganathan D; Saweirs W; Sud K; Toussaint ND; Walker RG; Williams LA; Yehia M; Mudge DW
Nephrol Dial Transplant; 2016 Apr; 31(4):619-27. PubMed ID: 25906780
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
5. Infection Prophylaxis in Peritoneal Dialysis Patients: Results from an Australia/New Zealand Survey.
Campbell DJ; Mudge DW; Gallagher MP; Lim WH; Ranganathan D; Saweirs W; Craig JC
Perit Dial Int; 2017; 37(2):191-197. PubMed ID: 28096438
[TBL] [Abstract][Full Text] [Related]
6. Effects of prophylactic antibiotics before peritoneal dialysis catheter implantation on the clinical outcomes of peritoneal dialysis patients.
Liu X; Zuo X; Sun X; Hu Z
Ren Fail; 2019 Nov; 41(1):16-23. PubMed ID: 30706749
[TBL] [Abstract][Full Text] [Related]
7. Variation in Peritoneal Dialysis-Related Peritonitis Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
Al Sahlawi M; Zhao J; McCullough K; Fuller DS; Boudville N; Ito Y; Kanjanabuch T; Nessim SJ; Piraino BM; Pisoni RL; Teitelbaum I; Woodrow G; Kawanishi H; Johnson DW; Perl J
Am J Kidney Dis; 2022 Jan; 79(1):45-55.e1. PubMed ID: 34052357
[TBL] [Abstract][Full Text] [Related]
8. Clusters of Practice in Peritoneal Dialysis in France: Data from the Catheter Section of the RDPLF.
Lanot A; Bechade C; Verger C; Fabre E; Vernier I; Lobbedez T
Perit Dial Int; 2018; 38(2):89-97. PubMed ID: 29162681
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
10. Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland.
Lichodziejewska-Niemierko M; Chmielewski M; Wojtaszek E; Suchowierska E; Gołembiewska E; Grajewska M; Matuszkiewicz-Rowińska J; Naumnik B; Sulikowska B; Niemczyk S; Kłak R; Mosakowska M; Jagodziński P; Marcykiewicz B; Kalita K; Krawczyk R; Cieszyński K; Adamski M; Bronk M
Int Urol Nephrol; 2019 Feb; 51(2):335-341. PubMed ID: 30604230
[TBL] [Abstract][Full Text] [Related]
11. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
14. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
16. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
[TBL] [Abstract][Full Text] [Related]
17. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.
Chen SS; Sheth H; Piraino B; Bender F
Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the management of infective complications of peritoneal dialysis.
Odudu A; Wilkie M
Nephron Clin Pract; 2011; 118(3):c301-8. PubMed ID: 21242698
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
